This trial is unknown!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Sleep Apnea, Obstructive, Continuous Positive Airway Pressure, Endothelium, Inflammation or Vascular Function
and you are
between 30 and 65
years old
The phase for this study is not defined.
Show me locations

The purpose

This purpose of this study is to 1. Determine the change in endothelial dependent vascular reactivity and vascular properties 2. Determine the changes in monocytes activation 3. Determine the change in pro-inflammatory status 4. Investigate the effect of six-month CPAP therapy on the above changes in patients with OSA

Provided treatments

  • Device: Therapeutic CPAP
  • Device: Subtherapeutic CPAP

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01312168. The sponsor of the trial is National Taiwan University Hospital and it is looking for 150 volunteers for the current phase.
Official trial title:
Endothelial Dysfunction, Monocyte Activation, and Vasculopathy in Patients With Obstructive Sleep Apnea and Effect of Six-month CPAP Treatment: A Large-scale, Double-blind, Randomized, Placebo-controlled Trial